Malaria Causes

QUESTION

What are the causes of malaria?

ANSWER

Malaria is caused by a parasite called Plasmodium, which is transmitted via the bites of infected mosquitoes. In the human body, the parasites multiply in the liver, and then infect red blood cells. Usually, people get malaria by being bitten by an infective female Anopheles mosquito. Only Anopheles mosquitoes can transmit malaria and they must have been infected through a previous blood meal taken on an infected person. When a mosquito bites an infected person, a small amount of blood is taken in which contains microscopic malaria parasites. About 1 week later, when the mosquito takes its next blood meal, these parasites mix with the mosquito’s saliva and are injected into the person being bitten.

Please see “Malaria Symptoms and Causes” for more.

Information About Malaria

QUESTION

What is malaria?

ANSWER

Malaria is a serious and sometimes fatal disease caused by a tiny parasite that commonly infects a certain type of mosquito (of the genus Anopheles) which feeds on humans. People who get malaria are typically very sick with high fevers, shaking chills, and flu-like illness. Four kinds of malaria parasites can infect humans: Plasmodium falciparum, P. vivax, P. ovale, and P. malariae. Infection with P. falciparum, if not promptly treated, may lead to death. Although malaria can be a deadly disease, illness and death from malaria can usually be prevented.

Malaria’s Scientific Name

QUESTION

What is malaria’s scientific name?

ANSWER

The genus name for the single-celled parasite which causes malaria is Plasmodium. In the genus, there are five species which infect humans: Plasmodium falciparum (the most deadly kind), P. vivax, P. ovale, P. malariae and P. knowlesi.

Malaria Drug Binding Site

QUESTION

What is malaria, and drug binding site?

ANSWER

Malaria is caused by a single-celled protozoan parasite of the genus Plasmodium. Five kinds of Plasmodium are known to infect people: P. falciparum, P. vivax, P. ovale, P. malariae and P. knowlesi.

There is no one drug binding site with respect to malaria: different anti-malarial drugs have different modes of action, and not all are well described. I will briefly outline the proposed mechanism of action of two of the most common types of anti-malarials: artemisinin (and derivatives) and chloroquine (quinine is thought to act similarly to chloroquine).

Artemisinin is thought to have anti-malarial properties by virtue of possessing an endoperoxide moiety, or double oxygen bridge (-Carbon-Oxygen-Oxygen-Carbon). In the presence of intracellular free ion, this moiety is converted by a chemical reaction to “free radicals”, atoms with unpaired electrons which are highly reactive. The free radicals act as alkylating agents and induce cell death, but only those that are already pathologically crippled, for example due to malaria infection. Another hypothesis is that the free radicals directly damage the malaria parasite.

Chloroquine is thought to act by causing buildup of the toxic by-product of hemoglobin metabolism, heme – the malaria parasite usually converts heme to hemozoin, a non-toxic crystal, and stores it in the digestive vacuole. When chloroquine diffuses into an infected red blood cell, it reacts with heme to “cap” it, preventing further conversion into hemozoin. Moreover, chloroquine also converts hemozoin into a highly toxic substance called the FP-Chloroquine complex. This build-up of toxicity leads to breakdown of the cell membrane, and eventual cell death and autodigestion.

Malaria Vaccine Research

QUESTION

Is there any research to produce anti malaria vaccine, if not, why?

ANSWER

There are many teams of scientists working hard to try to produce a malaria vaccine. In fact, only last year, the preliminary results of a vaccine trial were published. The vaccine, called RTS,S, has been produced by GlaxoSmithKline and is in the midst of Phase III trials in Africa. The preliminary results showed approximately a 50% reduction in malaria incidence, though it is not clear how much of that protection came from the vaccine and how much should be attributed to the vaccine adjunct (a compound given with the vaccine to boost immune responses).

The preliminary results also did not include analysis of how much the vaccine prevented mortality due to malaria, and levels of protection against severe malaria appeared to be low. However, we will have to wait until 2014 for the full and final results of the clinical trial to be made available. In the meantime, other vaccine candidates are being developed, but there are many challenges to overcome.

For example, there are five different types of malaria that infect people: these differ significantly in the way they develop in the human host, and so a vaccine appropriate for one may not be effective against the others. Most vaccine researchers are focusing on Plasmodium falciparum, the most deadly form of malaria, and a vaccine effective against this parasite would certainly do the most to reduce malaria-related mortality. However, Plasmodium vivax also causes high morbidity, particularly in Asia and the Pacific, and so should not be overlooked.

Moreover, within each of these species exist different strains in different areas, each of which can be markedly different from a genetic perspective. Finally, we do not yet fully understand the complex ways in which our immune system reacts to malaria. As such, this presents a challenge to developing an effective malaria vaccine, though many scientists are willing to address this challenge and have made big inroads in the search for a safe, effective vaccine. For more information on current efforts to develop a malaria vaccine, please see PATH’s Malaria Vaccine Initiative.

Malaria Transmission and Deaths in the United States

QUESTION

How do you get malaria? How does malaria come to the United States? How many people have died from malaria?

ANSWER

Malaria is caused by infection with single-celled parasites called Plasmodium. There are five different species which infect humans; of these, Plasmodium falciparum is the most deadly. The Plasmodium parasites are transmitted to humans through the bite of an infected female Anopheles mosquito; when these mosquitoes bite a human, they transfer some of the parasites in their saliva.

After undergoing one set of multiplications in the liver, the malaria parasites are released into the blood, where they repeatedly infect and destroy red blood cells, multiplying in the process. These cycles of infection and destruction of red blood cells cause the cyclical fever that is characteristic of malaria. Eventually, the parasite produces new types of cells, called gametocytes; if the patient is then bitten by another mosquito, the mosquito can take up gametocytes as well as blood when it feeds, and the cycle continues.

Malaria used to be relatively common in the United States, though usually only occurring during the summer months and restricted to the warm, wet south-eastern region. However, a concerted control campaign in the 1940s, focusing mainly on vector control (i.e. killing mosquito and reducing their opportunities for breeding) swiftly led to the eradication of malaria from the US.

Nowadays, virtually all malaria cases in the US are imported from abroad, whereby people get infected when traveling to other countries, but are only diagnosed as having malaria when they return home. There are about 1,000 cases of malaria reported each year in the US, and most of these were actually caught outside the US. Very rarely, an Anopheles mosquito will bite one of these travelers once they have returned from abroad, and therefore have the potential to transmit malaria within the US. However, due to a strong public health network and good access to malaria diagnosis and treatment, these events rarely lead to more than a handful of cases before they are quickly treated and transmission eliminated again.

The World Health Organisation estimates that last year, approximately 700,000 people died of malaria. Of these, 90% were in sub-Saharan Africa, and the vast majority were children under the age of 5.

What is malaria, and what causes it?

QUESTION

What is malaria and what causes it?

ANSWER

Malaria is caused by a parasite called Plasmodium, which is transmitted via the bites of infected mosquitoes. In the human body, the parasites multiply in the liver, and then infect red blood cells. Usually, people get malaria by being bitten by an infective female Anopheles mosquito. Only Anopheles mosquitoes can transmit malaria and they must have been infected through a previous blood meal taken on an infected person. When a mosquito bites an infected person, a small amount of blood is taken in which contains microscopic malaria parasites. About 1 week later, when the mosquito takes its next blood meal, these parasites mix with the mosquito’s saliva and are injected into the person being bitten.

Because the malaria parasite is found in red blood cells of an infected person, malaria can also be transmitted through blood transfusion, organ transplant, or the shared use of needles or syringes contaminated with blood. Malaria may also be transmitted from a mother to her unborn infant before or during delivery (“congenital” malaria).

Malaria Causes

QUESTION

What are the causes of malaria?

ANSWER

Malaria is caused by a parasite called Plasmodium, which is transmitted via the bites of infected mosquitoes. In the human body, the parasites multiply in the liver, and then infect red blood cells. Usually, people get malaria by being bitten by an infective female Anopheles mosquito. Only Anopheles mosquitoes can transmit malaria and they must have been infected through a previous blood meal taken on an infected person. When a mosquito bites an infected person, a small amount of blood is taken in which contains microscopic malaria parasites. About 1 week later, when the mosquito takes its next blood meal, these parasites mix with the mosquito’s saliva and are injected into the person being bitten.

Because the malaria parasite is found in red blood cells of an infected person, malaria can also be transmitted through blood transfusion, organ transplant, or the shared use of needles or syringes contaminated with blood. Malaria may also be transmitted from a mother to her unborn infant before or during delivery (“congenital” malaria).

Evolution of Malaria

QUESTION

how did malaria evolve?

ANSWER

Malaria in humans probably evolved independently several times, and both times likely due to a cross-over event from a closely related primate malaria. For example, Plasmodium vivax is evolutionarily closely related to several species of malaria found in macaque monkeys in south-east Asia, and so a cross-over of one of those species into human, with subsequent adaptation and speciation, is one hypothesis as to the origin of P. vivax. Conversely, some people argue that P. vivax emerged in Africa, due to the high prevalence of certain genetic traits in African populations (such as the Duffy negative antigen), which protect against P. vivax.

In contrast, P. falciparum is agreed to have emerged in sub-Saharan Africa, and likely in the Congo basin, though the exact source of its origin has been under recent scientific dispute. Until 2010, it was thought that P. falciparum had crossed over to humans from chimpanzees, as chimps are known to be infected with P. reichenowi, a species very closely related to P. falciparum. However, a paper was published in 2010 which had sampled Plasmodium parasites of gorillas and revealed new species of Plasmodium which are even more closely related to P. falciparum, suggesting that the cross-over occurred from gorillas to humans.

As you can see, humans are not the only primates to get malaria; many species of monkey and ape are also susceptible to Plasmodium species, and even lemurs have their own suite of Plasmodium parasites. Among the mammals, rodents also can get malaria, and bats are infected with Hepatocystis, a malaria-like parasite which also infects hippos, primates and rodents. However, no other species of mammal appears to be susceptible to Plasmodium/Hepatocystis, and the reasons for this are not entirely clear.

Plasmodium probably crossed over to mammals from birds or lizards, both of which are infected with a vast number of species of Plasmodium. It is unclear in which of these groups Plasmodium first emerged, though it likely evolved originally from another type of blood-borne parasite called Leucocytozoon, which infects birds and uses blackflies (genus Simulium) as vectors.

A sister group to Plasmodium, called Haemoproteus, also evolved from Leucocytozoon but utilises a variety of different vectors, including mosquitoes, biting midges (Culicoides), louse flies (Hippoboscidae) and tabanids (Tabanidae). Plasmodium, by contrast, exclusively uses mosquitoes as its vectors (apart from one species of lizard Plasmodium, P. mexicanum, which uses sandflies), but while mammalian Plasmodium is only transmitted by Anopheles mosquitoes, bird and lizard Plasmodium can be transmitted by Culex, Aedes, Culiseta, Anopheles, Mansonia and Psorophora. As such, understanding the patterns of vector and host switches within Plasmodium and related taxa can actually provide interesting insights into the genus’ evolutionary history.

Plasmodium

QUESTION

Is Plasmodium a bacteria. Why?

ANSWER

No, Plasmodium is actually a protozoan—that is, a single-celled organism that is usually microscopic and belongs to the Domain Eukaryota (which also includes all plants and animals, but excludes bacteria and archaea). More specifically, Plasmodium belongs to the Apicomplexa group of protozoans, which are characterised as being parasites of animals, and possessing several unique characteristics, such as an apical complex structure used for invading host cells, and from which the group derives its name.

Protozoans differ from bacteria in terms of evolutionary history as well as a number of key characteristics. For example, protozoans, like all eukaryotes, possess a membrane-bound nucleus and organelles, neither of which are seen in bacteria. Bacteria, moreover, can produce their own food (they are autotrophic), whereas protozoans tend to be heterotrophic and rely on other organisms for food.